Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Nevro
NVRO
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.74
0.02
0.35%
At Close: -
$5.70
-0.04
-0.70%
After Hours: 4:35 PM EDT
15 minutes delayed
Get Report
Comment
Nevro (NVRO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nevro (NYSE:NVRO) Stock
Nevro Stock (NYSE: NVRO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 24, 2024
Nevro Launches AI-Driven HFX AdaptivAI, The F...
Benzinga Newsdesk
Friday, August 09, 2024
Citigroup Upgrades Nevro to Neutral, Announce...
Benzinga Newsdesk
Thursday, August 08, 2024
Wolfe Research Upgrades Nevro to Peer Perform
Benzinga Newsdesk
Assessing Nevro: Insights From 9 Financial Analysts
Benzinga Insights
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Wednesday, August 07, 2024
JMP Securities Downgrades Nevro to Market Per...
Benzinga Newsdesk
Evaluating Nevro: Insights From 8 Financial Analysts
Benzinga Insights
RBC Capital Maintains Sector Perform on Nevro...
Benzinga Newsdesk
Baird Maintains Neutral on Nevro, Lowers Pric...
Benzinga Newsdesk
Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Wells Fargo Downgrades Nevro to Underweight, ...
Benzinga Newsdesk
JP Morgan Downgrades Nevro to Underweight
Benzinga Newsdesk
Nevro shares are trading lower after the comp...
Benzinga Newsdesk
Piper Sandler Maintains Underweight on Nevro,...
Benzinga Newsdesk
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, August 06, 2024
Nevro Sees Q3 2024 Worldwide Revenue $92M-$94...
Benzinga Newsdesk
Nevro Sees FY24 Adj. EBITDA $(20M)-$(18M)
Benzinga Newsdesk
Nevro shares are trading lower after the comp...
Benzinga Newsdesk
Nevro Q2 2024 GAAP EPS $(0.53) Beats $(0.68) ...
Benzinga Newsdesk
Tuesday, July 16, 2024
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Monday, July 15, 2024
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Nevr...
Benzinga Newsdesk
Thursday, July 11, 2024
Citigroup Maintains Sell on Nevro, Lowers Pri...
Benzinga Newsdesk
Wednesday, May 22, 2024
Citigroup Downgrades Nevro to Sell, Lowers Pr...
Benzinga Newsdesk
Wednesday, May 08, 2024
Assessing Nevro: Insights From 9 Financial Analysts
Benzinga Insights
Canaccord Genuity Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Nevro, ...
Benzinga Newsdesk
Piper Sandler Maintains Underweight on Nevro,...
Benzinga Newsdesk
Tuesday, May 07, 2024
Nevro Reaffirms FY24 Revenue Guidance Of $435...
Benzinga Newsdesk
Nevro Q1 2024 GAAP EPS $(0.70) Beats $(1.08) ...
Benzinga Newsdesk
Monday, April 15, 2024
RBC Capital Maintains Sector Perform on Nevro...
Benzinga Newsdesk
Thursday, April 11, 2024
Mizuho Maintains Neutral on Nevro, Lowers Pri...
Benzinga Newsdesk
Monday, April 08, 2024
Wells Fargo Maintains Equal-Weight on Nevro, ...
Benzinga Newsdesk
Wednesday, April 03, 2024
Where Nevro Stands With Analysts
Benzinga Insights
Citigroup Maintains Neutral on Nevro, Lowers ...
Benzinga Newsdesk
Wednesday, February 28, 2024
Nevro Receives FDA 510(k) Clearance To Use SI...
Benzinga Newsdesk
Thursday, February 22, 2024
Analyst Scoreboard: 4 Ratings For Nevro
Benzinga Insights
Wednesday, February 21, 2024
Nevro Expects Worldwide Revenue Of $435M-$445...
Benzinga Newsdesk
Nevro Enters Cooperation Agreement With Engag...
Benzinga Newsdesk
Nevro Q4 2023 GAAP EPS $(0.25) Beats $(0.49) ...
Benzinga Newsdesk
Nevro: Q4 Earnings Insights
Benzinga Insights
Earnings Scheduled For February 21, 2024
Benzinga Insights
Thursday, January 18, 2024
Nevro Announces Coverage Update From Carelon ...
Benzinga Newsdesk
Wednesday, January 17, 2024
Nevro To Highlight 25 Scientific Abstracts At...
Benzinga Newsdesk
Friday, January 12, 2024
What Analysts Are Saying About Nevro Stock
Benzinga Insights
RBC Capital Downgrades Nevro to Sector Perfor...
Benzinga Newsdesk
Tuesday, January 09, 2024
Nevro Announces Restructuring, Including Layi...
Benzinga Newsdesk
Nevro Sees Prelim. FY23 Revenue $425M Vs $418...
Benzinga Newsdesk
Nevro Sees Prelim. Q4 Revenue $116M Vs $109.2...
Benzinga Newsdesk
Friday, December 29, 2023
Nevro Filed Prospectus For Offering Of Up To 2.5M Shares Of Common Stock Offered By Selling Securityholde
Charles Gross
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch